U.S. Online Retail and Ecommerce Stock News

NasdaqGS:PICS
NasdaqGS:PICSDiversified Financial

PicS IPO Opens Brazilian Listings Return And Early Trading Test

PicS N.V. completed a US$434.3 million initial public offering. The company began trading on the Nasdaq Global Select Market under the ticker NasdaqGS:PICS. This is the first new stock listing by a Brazilian company in over four years. With its IPO now complete, PicS enters the public markets at a share price of $17.76 and a recent 7 day return of 17.6%. The listing of NasdaqGS:PICS also marks a return of Brazilian issuers to international equity markets after a multi year pause in new...
NasdaqGS:TERN
NasdaqGS:TERNPharmaceuticals

Terns Pharmaceuticals (TERN) Valuation Check After Strong Recent Share Price Run And CML Narrative Shift

Terns Pharmaceuticals (TERN) has drawn attention after recent trading, with the stock closing at US$40.92. For investors, the clinical stage focus on oncology and obesity raises questions about how current pricing reflects trial progress and cash needs. See our latest analysis for Terns Pharmaceuticals. While the share price slipped around 1% on the day to US$40.92, it remains on a strong short term run, with a 16.61% 1 month share price return and a 45.57% 3 month share price return,...
NYSE:NSA
NYSE:NSASpecialized REITs

National Storage Affiliates Trust Sharpens Platform With Q4 Progress And Portfolio Moves

National Storage Affiliates Trust (NYSE:NSA) reported solid Q4 operational progress, including better occupancy metrics and revenue trends across most markets. The company completed the consolidation of another brand, aiming to simplify its platform and improve operational consistency. NSA continued to refine its portfolio through asset sales, new acquisitions and joint ventures, while keeping liquidity conditions supportive of these moves. For investors tracking NYSE:NSA, the recent...
NasdaqGS:CHDN
NasdaqGS:CHDNHospitality

Churchill Downs (CHDN) Margin Decline Tests Bullish Growth Narratives After FY 2025 Results

Churchill Downs (CHDN) has wrapped up FY 2025 with fourth quarter revenue of US$665.9 million and basic EPS of US$0.71, alongside trailing twelve month revenue of US$2.9 billion and EPS of US$5.36. The company has seen quarterly revenue move from US$624.2 million in Q4 2024 to US$665.9 million in Q4 2025, while basic EPS shifted from US$0.99 to US$0.71 over the same period. This sets up a contrast with a trailing net margin of 13.1% versus 15.6% a year earlier, which keeps investor attention...
NasdaqGM:IRON
NasdaqGM:IRONBiotechs

Disc Medicine Refocuses On APOLLO Trial After FDA Letter For Bitopertin

Disc Medicine (NasdaqGM:IRON) received a Complete Response Letter from the FDA for its bitopertin candidate for erythropoietic protoporphyria, shifting the drug to a traditional approval pathway. The company now plans to rely on its ongoing APOLLO Phase III trial as the core data package for future regulatory submissions. Management expects APOLLO to reach full enrollment soon, making the trial a key focus for the bitopertin program. For you as an investor, this update centers on how Disc...
NasdaqCM:RGTI
NasdaqCM:RGTISemiconductor

Is Rigetti Computing (RGTI) Pricing Reflect Its Quantum Roadmap After 120% One-Year Surge

If you are wondering whether Rigetti Computing's recent share price puts it above or below a reasonable value, you are not alone. This article is designed to help you frame that question clearly. Rigetti's stock closed at US$18.64, with a 17.1% return over the past week, a 15.3% decline over the past month, a 21.0% decline year to date, and a 120.3% return over the past year. These moves may leave you questioning whether the current price reflects opportunity or higher risk. Recent news...
NasdaqGS:STRL
NasdaqGS:STRLConstruction

Sterling Infrastructure (STRL) Margin Slippage And EPS Softening Test Bullish Growth Narratives

Sterling Infrastructure (STRL) has wrapped up FY 2025 with fourth quarter revenue of US$755.6 million and basic EPS of US$2.85, alongside net income of US$87.6 million, setting a clear marker for how the year finished. Over the past six quarters, the company has seen quarterly revenue move from US$498.8 million in Q4 2024 to US$755.6 million in Q4 2025, while basic EPS shifted from US$3.69 to US$2.85 and trailing twelve month EPS went from US$5.98 in Q3 2024 to US$9.50 in Q4 2025, giving...
NYSE:PERF
NYSE:PERFSoftware

Is Perfect (PERF) Quietly Reframing Its Moat Around B2B Beauty Personalization APIs?

Perfect Corp. recently announced a partnership with True Beauty Lashes to power LashLovr™, an AI-driven lash matching and virtual try-on experience that uses its Virtual Try-On and Face Analyzer APIs to help shoppers find better-fitting false lashes in real time. This collaboration highlights how Perfect’s pay-as-you-go AI and AR APIs can lower adoption hurdles for beauty brands while showcasing a concrete, research-backed use case that could support broader B2B uptake of its technology...
NYSE:ACN
NYSE:ACNIT

US Stock Market Today S&P 500 Futures Ease As Housing And Factory Signals Diverge

The Morning Bull - US Market Morning Update Friday, Feb, 27 2026 US stock futures are pointing slightly lower this morning, with E-mini S&P 500 futures down about 0.2%, as investors weigh cheaper borrowing costs against mixed global growth signals. The 30 year US mortgage rate has dipped below 6% to 5.98%, which can make monthly payments a bit less painful and puts housing related names in focus. At the same time, the Kansas Fed Manufacturing Index has bounced to 10, a sign that factory...
NYSE:GIC
NYSE:GICTrade Distributors

Is It Time To Reassess Global Industrial (GIC) After Its Strong 1 Year Share Price Run

Are you wondering if Global Industrial still offers good value after its recent run, or if the current price already reflects the key positives for the business? The stock last closed at US$33.26, with returns of 4.3% over 7 days, 9.9% over 30 days, 13.1% year to date, 48.4% over 1 year, 32.6% over 3 years and 10.4% over 5 years. This naturally raises questions about what is now priced in. Recent coverage has focused on Global Industrial's role as a distributor of industrial and business...
NYSE:SPXC
NYSE:SPXCMachinery

SPX Technologies Reshapes Business With Deals Earnings And Shifting Ownership

SPX Technologies is pursuing an acquisition-led expansion and investing heavily in capacity, including in data center infrastructure. The company recently reported record earnings that align with this repositioning of its business mix. At the same time, insider selling and shifts in institutional ownership are reshaping who holds NYSE:SPXC shares. For investors, this mix of corporate activity and ownership changes makes NYSE:SPXC a stock to watch. The shares recently closed at $231.59, with...
NasdaqGS:RARE
NasdaqGS:RAREBiotechs

Ultragenyx Priority Review For DTX401 Spurs Fresh Look At Valuation

Ultragenyx Pharmaceutical (NasdaqGS:RARE) announced that the US FDA has accepted its Biologics License Application for DTX401, a gene therapy for Glycogen Storage Disease Type Ia. The FDA has granted Priority Review to the application, signaling an expedited assessment timeline. If approved, DTX401 could become the first pharmacologic treatment option for people living with Glycogen Storage Disease Type Ia. For Ultragenyx, with a current share price of $23.04, this regulatory milestone...
NYSE:ASPN
NYSE:ASPNChemicals

Why Aspen Aerogels (ASPN) Is Down 13.3% After Impairment-Driven Loss And Strategic Review News

In February 2026, Aspen Aerogels reported fourth-quarter 2025 sales of US$41.34 million versus US$123.09 million a year earlier, swung to a net loss of US$72.91 million, recorded an impairment charge on property, plant and equipment, and launched a broad review of options for its business and capital structure. An important insight is that management characterizes this strategic review as coming from a position of financial strength and operational progress, even as the company posts a...
NasdaqGS:NVDA
NasdaqGS:NVDASemiconductor

Nvidia (NVDA) Margins Near 56% Reinforce Bullish AI Narrative Despite Cash Quality Doubts

Nvidia (NVDA) has put up big headline numbers for FY 2026, with fourth quarter revenue of about US$68.1b and basic EPS of US$1.77, capping a year in which trailing 12 month EPS reached US$4.93 alongside revenue of roughly US$215.9b. Over the past six quarters, the company has seen quarterly revenue move from about US$35.1b with EPS of US$0.79 in FY 2025 Q3 to US$68.1b and EPS of US$1.77 in FY 2026 Q4. This sets up a story where investors are watching how rich margins and strong earnings...
NasdaqGS:GTX
NasdaqGS:GTXAuto Components

Garrett Motion Cling Deal Links EV HVAC Growth To Turbocharger Future

Garrett Motion (NasdaqGS:GTX) agreed to supply its oil free centrifugal compressor to Cling for use in China's next generation electric buses and trucks. The deal represents Garrett Motion's first serial award for its oil free, foil bearing based centrifugal compressor within the mobility sector. The compressor is intended to support advanced HVAC systems that focus on energy efficiency, compact size, reduced noise, and durability for commercial EVs in China. Garrett Motion, best known for...
NasdaqGS:SBCF
NasdaqGS:SBCFBanks

Is Seacoast Banking Corporation of Florida (SBCF) Pricing Reflecting Its Mixed Valuation Signals?

If you are wondering whether Seacoast Banking Corporation of Florida is currently priced attractively, you are not alone. The stock has drawn interest from investors trying to work out if today’s share price lines up with its fundamentals. Over the past year, the share price return sits at 21.0%, with a 4.1% gain year to date. This comes even though the last 7 and 30 days have seen modest pullbacks of 1.8% and 2.2% respectively from the recent close at US$32.90. Recent coverage of regional...
NasdaqGS:TCBK
NasdaqGS:TCBKBanks

Is It Time To Reconsider TriCo Bancshares (TCBK) After Its Recent Share Price Performance?

If you are wondering whether TriCo Bancshares is fairly priced or offering value at its recent levels, this article will walk you through what the numbers actually say about the stock. The share price last closed at US$49.77, with returns of a 0.9% decline over 7 days, 1.4% over 30 days, 5.6% year to date, 18.6% over 1 year and 26.7% over 5 years. This naturally raises questions about how much is already reflected in the price and how much risk is being priced in. Recent coverage of TriCo...
NYSE:CRI
NYSE:CRILuxury

Is It Time To Rethink Carter's (CRI) Valuation After Its Recent Share Price Rebound?

If you are wondering whether Carter's current share price offers value or potential risk, starting with the recent share performance and valuation checks can give you a clearer picture. Carter's shares last closed at US$42.07, with returns of 0.1% over 7 days, 20.7% over 30 days, 26.7% year to date, 4.4% over 1 year, along with 36.1% and 38.8% declines over 3 and 5 years respectively. Recent news coverage has focused on Carter's positioning in the childrenswear market and investor interest...
NasdaqCM:SKYT
NasdaqCM:SKYTSemiconductor

SkyWater Technology (SKYT) Q4 Loss Challenges Bullish Narrative After Q3 EPS Surge

SkyWater Technology (SKYT) Posts Mixed FY 2025 Finish With Big Q3 EPS Spike and Q4 Loss SkyWater Technology (SKYT) closed out FY 2025 with Q4 revenue of US$171.0 million and a basic EPS loss of US$0.16, following a Q3 that featured US$150.7 million in revenue and a sharp basic EPS jump to US$2.98 on net income of US$144.0 million. Over recent periods the company has seen quarterly revenue move from US$75.5 million in Q4 2024 to US$61.3 million in Q1 2025, US$59.1 million in Q2 2025, and then...
NYSE:ONTF
NYSE:ONTFSoftware

ON24 (ONTF) Quarterly Losses Persist And Test Bullish Narratives On Profitability Path

ON24 (ONTF) has wrapped up FY 2025 with fourth quarter revenue of US$34.6 million and a basic EPS loss of US$0.15, as net income excluding extra items came in at a loss of US$6.5 million. Over recent quarters the company has seen revenue hold in a tight band between US$34.6 million and US$36.7 million, while quarterly basic EPS losses have ranged from US$0.15 to US$0.27 over the periods shown. This gives investors a clearer view of how top line scale lines up against persistent losses. With...
NYSE:ADT
NYSE:ADTConsumer Services

ADT Bets On Camera Free AI Sensing And Verisure Partnership Potential

ADT (NYSE:ADT) has acquired Origin AI, a company focused on camera free AI presence sensing technology. The deal includes Origin AI's patent portfolio and will be integrated into ADT's smart home security platform. ADT has also signed a long term commercial agreement with Verisure to bring this AI sensing technology to Europe and Latin America. For investors watching NYSE:ADT at a share price of $8.11, this move signals a push to differentiate its smart home offering with AI driven presence...
NasdaqGS:TWFG
NasdaqGS:TWFGInsurance

TWFG (TWFG) Net Margin Recovery Tests Bullish Long Term Earnings Narrative

TWFG (TWFG) has just posted its FY 2025 numbers, with Q4 revenue at US$68.8 million and basic EPS of US$0.18. This caps off a trailing twelve month profile that includes revenue of US$247.1 million and basic EPS of US$0.51 alongside reported earnings growth of 179.5% over the past year. The company has seen revenue rise from US$49.5 million in Q4 2024 to US$68.8 million in Q4 2025, while quarterly EPS has moved from US$0.11 to US$0.18. This sets the backdrop for analyst forecasts that point...
NYSE:AMBP
NYSE:AMBPPackaging

Ardagh Metal Packaging (AMBP) Margins Stay Fragile As Profit Swings Challenge Bullish Earnings Narratives

Ardagh Metal Packaging (NYSE:AMBP) has wrapped up FY 2025 with fourth quarter revenue of US$1.3b and a basic EPS loss of US$0.03, alongside net income excluding extra items of a US$16m loss. Over recent periods the company has seen revenue move from US$1.2b in Q4 2024 to US$1.3b in Q4 2025, with quarterly EPS ranging between a loss of US$0.03 and a profit of roughly US$0.04, while trailing twelve month net income excluding extra items sits at US$11m on US$5.5b of revenue. With the company now...
NasdaqCM:IKT
NasdaqCM:IKTBiotechs

A Look At Inhibikase Therapeutics (IKT) Valuation After New FDA Designations And Phase 2a Trial Progress

Inhibikase Therapeutics (IKT) has moved into focus after fresh FDA designations and progress in its Phase 2a trial for IkT-148009 targeting Parkinson’s disease, even as ongoing financial instability remains part of the picture. See our latest analysis for Inhibikase Therapeutics. The recent FDA designations and Phase 2a progress appear to be feeding into momentum, with a 7 day share price return of 20.11% and a 90 day share price return of 37.50%, even though the 1 year total shareholder...